NHI · National Health Investors Inc
$65.63
-1.03 (-1.55%)
At close · Sep 30
Ex-dividend: $0.94 · Sep 30, 2026
Return incl. dividend (before tax)
-0.14%
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.”View the 10-Q filed Aug 10, 2026
Market Cap
$3.29B
Shares
49.11M
Volume · Sep 30
432.93K
Avg daily vol (3M)
390.49K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$66.66
Open$66.51
Day$66.50–67.39
52W close$66.66–91.02
Avg vol 30d350K
Short int2.0M · 4.1% float · 6.0d
Short vol57%
Last earningsAug 11, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 10
Up next
Next earnings call
Nov 14, 2026
Est · unconfirmed
· in 6 wks
filed Aug 10, 2026
call held May 5, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$432.12M
Trailing 12 months
Net income (TTM)
$166.80M
Trailing 12 months
Revenue growth YoY
+33.8%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
19.3
Trailing earnings · reciprocal yield 5.2%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
1.4%
Trailing 12 months
Shares change YoY
+3.6%
Year over year · more shares
Price change (1Y)
-15.2%
Trailing year
Short interest
4.1%
Latest settlement · 6.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Low
Market backdrop
VIX 16 · calm
Equity put/call 0.38
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−14%
below
Price vs 50-day avg
−8%
below
RSI (14)
28
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−21%
trailing
YTD return
−13%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $73 › 200d $78 — 200d above 50d
Institutional flow
Distributing
-4% holders QoQ · +41 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.09% of float · ▼ -11.0% MoM · 6.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
306 holders — mid 3-yr range
Squeeze score
53
elevated · 0–100
Fundamentals
Revenue growth
+12%
Y/Y
EPS growth
−4%
Y/Y
Free cash flow
$-57.5M
Valuation
P/E 19.3
below peers
Buyback
$500.0M
authorized
Balance sheet
$1.1B
net debt
Quant / Vol
risk profile
Volatility
24%
annualized · 1-yr
Max drawdown
−27%
past year
ATR
2.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 10, 2026
NAREIT FFO per diluted share
· 2026 Full-Year
Non-GAAP
Initiated
$4.74 – $4.79
Same Store SHOP NOI growth
· 2026 Full-Year
Initiated
1% – 3%
Normalized FFO per diluted share
· 2026 Full-Year
Non-GAAP
Initiated
$4.74 – $4.79
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−14%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
28
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $73 › 200d $78 — 200d above 50d
Institutional flow
Distributing
-4% holders QoQ · +41 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.09% of float · ▼ -11.0% MoM · 6.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
306 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $67
Now $67 · 0%
Range high $91
vs 200-day avg -14%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $75.64M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net income $55.36M
+$25.55M Depreciation and amortization
+$15.81M Interest expense
+$213K Franchise, excise and other taxes
+$732K Income tax expense
-$59K Loan and realty gains, net
-$21.97M Gains on dispositions of real estate properties
+$0K Write-offs of transaction costs
= Adjusted EBITDA $75.64M
|
|||
| Bickford average occupancy rate | 84.7% | Q2 2026 filing | — |
| NAREIT FFO attributable to common stockholders per share non-GAAP | $1.19 | Three Months Ended June 30, 2026 filing | — |
| Normalized FAD attributable to common stockholders non-GAAP | $61.62M | Three Months Ended June 30, 2026 filing | — |
| Normalized FFO attributable to common stockholders per share non-GAAP | $1.19 | Three Months Ended June 30, 2026 filing | — |
| Number of properties in Total SHOP segment | 42 | Q2 2026 filing | — |
| Real Estate Investments portfolio occupancy ratio (Total) | 85.1% | Q1 2026 filing | — |
| Senior Living average occupancy rate | 86.3% | Q2 2026 filing | — |
| SHOP segment average occupancy rate | 85.1% | Q2 2026 filing | — |
| Total SHOP segment average occupancy rate | 85.9% | Q2 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHI
this stock
National Health Investors Inc
|
$3.29B | -12.7% | +12.1% | 19.3 | 4.1% |
|
WELL
Welltower Inc.
|
$163.33B | +25.5% | +35.6% | 115.1 | 2.5% |
|
VTR
Ventas, Inc.
|
$44.42B | +12.3% | +18.5% | 160.4 | 3.9% |
|
DOC
Healthpeak Properties, Inc.
|
$14.12B | +25.2% | +4.5% | 58.5 | 3.7% |
|
OHI
Omega Healthcare Investors Inc
|
$14.02B | +5.0% | +13.2% | 16.5 | 4.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHI | -1.1% | -6.3% | -21.3% | -6.3% | -12.7% |
| SPY | -1.2% | -0.4% | +13.1% | -0.4% | +12.1% |
| vs SPY | +0.1% | -5.9% | -34.4% | -5.9% | -24.8% |
Capital returns
Latest dividend
$0.94
/ share · ex Sep 30, 2026
Paid (TTM)
$0.94
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Buyback program
· as of Jun 30, 2026
Authorized
$500.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.